Published in J Womens Health (Larchmt) on March 01, 2005
Developing a systematic approach to safer medication use during pregnancy: summary of a Centers for Disease Control and Prevention--convened meeting. Am J Obstet Gynecol (2014) 2.00
Providing contraception for women taking potentially teratogenic medications: a survey of internal medicine physicians' knowledge, attitudes and barriers. J Gen Intern Med (2010) 1.11
Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies. Emerg Infect Dis (2006) 1.11
The Most Commonly Dispensed Prescription Medications Among Pregnant Women Enrolled in the U.S. Medicaid Program. Obstet Gynecol (2015) 1.09
Prevalence of prescription medication use among non-pregnant women of childbearing age and pregnant women in the United States: NHANES, 1999-2006. Matern Child Health J (2015) 0.89
Trends and Determinants of Prescription Drug Use during Pregnancy and Postpartum in British Columbia, 2002-2011: A Population-Based Cohort Study. PLoS One (2015) 0.82
Enquiry analysis and user opinion of the Drugs in Breastmilk Helpline: a prospective study. Int Breastfeed J (2012) 0.81
The need for safer medication use in pregnancy. Expert Rev Clin Pharmacol (2013) 0.80
Assessment of congenital anomalies in infants born to pregnant women enrolled in clinical trials. Clin Infect Dis (2014) 0.80
Assessment of clinical outcomes and prescribing behavior among inpatients with severe preeclampsia and eclampsia: an Indian experience. Indian J Pharmacol (2014) 0.78
A survey and analysis of using traditional Chinese medicine during pregnancy. Int J Clin Exp Med (2015) 0.75
H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet (2009) 12.32
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA (2010) 5.94
Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics (2005) 4.91
Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol (2011) 4.14
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med (2007) 3.79
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet (2002) 3.35
Reporting birth defects surveillance data 1968-2003. Birth Defects Res A Clin Mol Teratol (2007) 3.29
The contribution of preterm birth to infant mortality rates in the United States. Pediatrics (2006) 3.01
A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics (2003) 2.88
Emerging infections and pregnancy. Emerg Infect Dis (2006) 2.75
Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics (2006) 2.53
Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med (2007) 2.43
Maternal obesity and risk for birth defects. Pediatrics (2003) 2.33
Pandemic influenza and pregnant women: summary of a meeting of experts. Am J Public Health (2009) 2.09
What obstetrician-gynecologists should know about Ebola: a perspective from the Centers for Disease Control and Prevention. Obstet Gynecol (2014) 2.04
Maternal nutrient intakes and risk of orofacial clefts. Epidemiology (2006) 1.70
2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol (2011) 1.69
Association between pregnancy intention and reproductive-health related behaviors before and after pregnancy recognition, National Birth Defects Prevention Study, 1997-2002. Matern Child Health J (2009) 1.68
Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology (2007) 1.67
Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol (2011) 1.66
Prescription medication borrowing and sharing among women of reproductive age. J Womens Health (Larchmt) (2008) 1.64
A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003. Am J Med Genet A (2008) 1.63
Are children born after assisted reproductive technology at increased risk for adverse health outcomes? Obstet Gynecol (2004) 1.61
Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol (2012) 1.56
Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.56
Orofacial clefts in the National Birth Defects Prevention Study, 1997-2004. Am J Med Genet A (2009) 1.55
Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep (2004) 1.52
Health concerns of women and infants in times of natural disasters: lessons learned from Hurricane Katrina. Matern Child Health J (2007) 1.48
Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol (2009) 1.38
FRIL: A tool for comparative record linkage. AMIA Annu Symp Proc (2008) 1.38
Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol (2007) 1.34
Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.29
Patterns of antidepressant medication use among pregnant women in a United States population. J Clin Pharmacol (2010) 1.28
Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk. Pharmacoepidemiol Drug Saf (2013) 1.25
The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol (2011) 1.24
Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.21
Maternal attitudes toward DNA collection for gene-environment studies: a qualitative research study. Am J Med Genet A (2009) 1.18
Priorities for future public health research in orofacial clefts. Cleft Palate Craniofac J (2007) 1.18
Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am J Med Genet A (2009) 1.17
Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn. N Engl J Med (2006) 1.16
Trisomies 13 and 18: population prevalences, characteristics, and prenatal diagnosis, metropolitan Atlanta, 1994-2003. Am J Med Genet A (2008) 1.13
Maternal periconceptional alcohol consumption and risk of orofacial clefts. Am J Epidemiol (2007) 1.13
Correlates of seasonal influenza vaccine coverage among pregnant women in Georgia and Rhode Island. Obstet Gynecol (2010) 1.13
Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies. Emerg Infect Dis (2006) 1.11
Lymphocytic choriomeningitis virus: an emerging obstetric pathogen? Am J Obstet Gynecol (2006) 1.11
Zika Virus Infection Among U.S. Pregnant Travelers - August 2015-February 2016. MMWR Morb Mortal Wkly Rep (2016) 1.08
Obstetrician/gynecologists' knowledge, attitudes, and practices regarding prevention of infections in pregnancy. J Womens Health (Larchmt) (2009) 1.03
Prevalence of self-reported infection during pregnancy among control mothers in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2009) 1.02
Population-based study of congenital diaphragmatic hernia: risk factors and survival in Metropolitan Atlanta, 1968-1999. Birth Defects Res A Clin Mol Teratol (2003) 1.02
Are encephaloceles neural tube defects? Pediatrics (2006) 1.01
Varicella vaccine exposure during pregnancy: data from 10 Years of the pregnancy registry. J Infect Dis (2008) 1.01
Risk factors for non-syndromic holoprosencephaly in the National Birth Defects Prevention Study. Am J Med Genet C Semin Med Genet (2010) 1.01
Fetal constraint as a potential risk factor for craniosynostosis. Am J Med Genet A (2010) 1.00
Health of children 3 to 17 years of age with Down syndrome in the 1997-2005 national health interview survey. Pediatrics (2009) 0.99
Current estimate of Down Syndrome population prevalence in the United States. J Pediatr (2013) 0.98
Prepregnancy obesity: a complex risk factor for selected birth defects. Birth Defects Res A Clin Mol Teratol (2010) 0.98
Seasonal influenza vaccine coverage among pregnant women: pregnancy risk assessment monitoring system. J Womens Health (Larchmt) (2011) 0.97
Risk of birth defects among children conceived with assisted reproductive technology: providing an epidemiologic context to the data. Fertil Steril (2005) 0.96
Pregnancy termination following prenatal diagnosis of anencephaly or spina bifida: a systematic review of the literature. Birth Defects Res A Clin Mol Teratol (2012) 0.96
Maternal use of bupropion and risk for congenital heart defects. Am J Obstet Gynecol (2010) 0.96
Association between reported venlafaxine use in early pregnancy and birth defects, national birth defects prevention study, 1997-2007. Birth Defects Res A Clin Mol Teratol (2012) 0.96
Examining the evidence for vascular pathogenesis of selected birth defects. Am J Med Genet A (2010) 0.95
Knowledge and attitudes of adults towards smoking in pregnancy: results from the HealthStyles© 2008 survey. Matern Child Health J (2015) 0.95
Zika Virus and Pregnancy: What Obstetric Health Care Providers Need to Know. Obstet Gynecol (2016) 0.94
Maternal exposure to statins and risk for birth defects: a case-series approach. Am J Med Genet A (2008) 0.93
Association between maternal age and birth defects of unknown etiology: United States, 1997-2007. Birth Defects Res A Clin Mol Teratol (2012) 0.93
Qualitative assessment of study materials and communication strategies used in studies that include DNA collection. Am J Med Genet A (2011) 0.92
Associations between periconceptional alcohol consumption and craniosynostosis, omphalocele, and gastroschisis. Birth Defects Res A Clin Mol Teratol (2011) 0.92
Updated preparedness and response framework for influenza pandemics. MMWR Recomm Rep (2014) 0.92
Cancer in children with nonchromosomal birth defects. J Pediatr (2012) 0.92
Nutrient intakes in women and congenital diaphragmatic hernia in their offspring. Birth Defects Res A Clin Mol Teratol (2008) 0.92
Effect of specimen storage conditions on newborn dried blood spots used to assess Toxoplasma gondii immunoglobulin M (IgM). Clin Chim Acta (2010) 0.92
Update: Interim Guidelines for Health Care Providers Caring for Infants and Children with Possible Zika Virus Infection - United States, February 2016. MMWR Morb Mortal Wkly Rep (2016) 0.92
Descriptive epidemiology of infantile cataracts in metropolitan Atlanta, GA, 1968-1998. Arch Pediatr Adolesc Med (2003) 0.92
Evaluation of mailed pediatric buccal cytobrushes for use in a case-control study of birth defects. Birth Defects Res A Clin Mol Teratol (2011) 0.91
Fine-grained record integration and linkage tool. Birth Defects Res A Clin Mol Teratol (2008) 0.91
Update: Interim Guidance for the Evaluation and Management of Infants with Possible Congenital Zika Virus Infection - United States, August 2016. MMWR Morb Mortal Wkly Rep (2016) 0.90
Survival among people with Down syndrome: a nationwide population-based study in Denmark. Genet Med (2012) 0.90
Obstetrician-gynaecologist knowledge of and access to information about the risks of medication use during pregnancy. J Matern Fetal Neonatal Med (2010) 0.90
Selected birth defects data from population-based birth defects surveillance programs in the United States, 2005–2009: Featuring critical congenital heart defects targeted for pulse oximetry screening. Birth Defects Res A Clin Mol Teratol (2012) 0.90
Genomic DNA methylation changes in response to folic acid supplementation in a population-based intervention study among women of reproductive age. PLoS One (2011) 0.90
Non-genetic risk factors for holoprosencephaly. Am J Med Genet C Semin Med Genet (2010) 0.89
Emerging and zoonotic infections in women. Infect Dis Clin North Am (2008) 0.89
Craniosynostosis and nutrient intake during pregnancy. Birth Defects Res A Clin Mol Teratol (2010) 0.88
Benefits of influenza vaccination during pregnancy for pregnant women. Am J Obstet Gynecol (2012) 0.88
Craniosynostosis and maternal smoking. Birth Defects Res A Clin Mol Teratol (2008) 0.88
Methods for a public health response to birth defects clusters. Teratology (2002) 0.88
Maternal bronchodilator use and the risk of orofacial clefts. Hum Reprod (2011) 0.88
Anthrax cases in pregnant and postpartum women: a systematic review. Obstet Gynecol (2012) 0.88
Estimating Contraceptive Needs and Increasing Access to Contraception in Response to the Zika Virus Disease Outbreak - Puerto Rico, 2016. MMWR Morb Mortal Wkly Rep (2016) 0.87
Maternal caffeine intake and risk of selected birth defects in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2011) 0.87
Research on vaccines during pregnancy: protocol design and assessment of safety. Vaccine (2013) 0.87
Maternal thyroid disease, thyroid medication use, and selected birth defects in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2009) 0.87
Modeling the potential public health impact of prepregnancy obesity on adverse fetal and infant outcomes. Obesity (Silver Spring) (2013) 0.87
Barriers to successful dietary control among pregnant women with phenylketonuria. Genet Med (2002) 0.87
2009 pandemic influenza A (H1N1) virus infection in postpartum women in California. Am J Obstet Gynecol (2010) 0.87